Implementation of artificial intelligence in healthcare in Aotearoa New Zealand: learnings from the diabetic retinal screening use case
New Zealand Medical Journal · 26.06.2026 · 139 (1637) · 131-136
DOI: 10.26635/6965.7342 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Zealand Medical Journal, online erschienen am 26.06.2026. Verfasst von Rosie Dobson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Principal Advisor, AI Research and Evaluation, Health New Zealand - Te Whatu Ora, Aotearoa New Zealand; Associate Professor, School of Population Hea…. Hauptthemen laut MEDLINE: Artificial Intelligence, Diabetic Retinopathy, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Artificial intelligence (AI) tools in diabetic retinal screening (DRS) are currently in use overseas within public health systems, with growing evidence of effectiveness. A proof of concept aimed at piloting a model of care for AI-integrated DRS to increase access to timely screening for Pacific peoples in Aotearoa New Zealand was undertaken but faced a range of challenges. What appeared to many as a straightforward AI use case proved not to be so in many ways. Challenges arose from issues related to the digital systems, challenges with adjusting models of care, variable clinician readiness and the appropriateness of the AI tools. These challenges are not unique and need to be overcome to realise the benefits of AI across many use cases. Careful planning, adequate resourcing and organisational buy-in and support are all required for any AI implementation projects to succeed and for the benefits to the population and health system to be realised.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Principal Advisor, AI Research and Evaluation, Health New Zealand - Te Whatu Ora, Aotearoa New Zealand; Associate Professor, School of Population Health, The University of Auckland, Aotearoa New Zealand.
- Clinical Director, AI Laboratory, Health New Zealand - Te Whatu Ora, Aotearoa New Zealand.
- Clinical Director, Evidence & Pathways, Data & Analytics, Health New Zealand - Te Whatu Ora, Aotearoa New Zealand; Professor, School of Population Health, The University of Auckland, Aotearoa New Zealand.
Zitieren
APA
Dobson, R., Kai Jin, C., & Whittaker, R. (2026). Implementation of artificial intelligence in healthcare in Aotearoa New Zealand: learnings from the diabetic retinal screening use case. New Zealand Medical Journal, 139(1637), 131-136. https://doi.org/10.26635/6965.7342
Vancouver
Dobson R, Kai Jin C, Whittaker R. Implementation of artificial intelligence in healthcare in Aotearoa New Zealand: learnings from the diabetic retinal screening use case. New Zealand Medical Journal. 2026;139(1637):131-136. doi:10.26635/6965.7342
BibTeX
@article{Dobson2026,
author = {Dobson, Rosie and Kai Jin, Cheng and Whittaker, Robyn},
title = {Implementation of artificial intelligence in healthcare in Aotearoa New Zealand: learnings from the diabetic retinal screening use case},
journal = {New Zealand Medical Journal},
year = {2026},
volume = {139},
number = {1637},
pages = {131--136},
doi = {10.26635/6965.7342}
}
EUVIMED